N44CO140040-000 (N44) | |||
---|---|---|---|
Title | SBIR Phase II, Topic 255: Development of Novel Anticancer Agent to Potentiate Se | ||
Institution | A&G PHARMACEUTICAL, INC, COLUMBIA, MD | ||
Principal Investigator | SERRERO, GINETTE | NCI Program Director | |
Cancer Activity | Division | ||
Funded Amount | $1,478,552 | Project Dates | 09/19/2014 - 09/18/2016 |
Fiscal Year | 2014 | Project Type | Contract |
Research Topics w/ Percent Relevance | Cancer Types w/ Percent Relevance | ||
Cancer (100.0%) |
Breast (50.0%) Lung (50.0%) |
||
Research Type | |||
Systemic Therapies - Discovery and Development | |||
Abstract | |||
No abstract available. |